Literature DB >> 33594930

The presence and progression of choroidal neurofibromas in a predominantly pediatric population with neurofibromatosis type-1.

Corina M Chilibeck1,2, Shaheen Shah1,3, Heather C Russell1,4, Andrea L Vincent1,2.   

Abstract

Background: Obtaining a definitive neurofibromatosis type-1 (NF1) diagnosis may take years. The natural history of choroidal neurofibromas in NF1 is unknown. This study evaluates a predominantly pediatric patient cohort for ocular features in NF1, including presence and progression of choroidal abnormalities, to determine their natural history, relationship to other NF1 features, and additive value in NF1 diagnosis.
Methods: Retrospective analysis of 106 patients referred for Ophthalmic monitoring or diagnosis of NF1 between January 2012 and December 2018. Clinical records and Near-Infrared Reflectance (NIR) Optical Coherence Tomography imaging were analyzed for prevalence and progression of choroidal neurofibromas on NIR, and relation to other NF1 diagnostic criteria.
Results: 54.7% of patients referred had a confirmed NF1 diagnosis, and 45.4% were NF1 suspects. First ophthalmic review resulted in an additional 6.6% patients meeting the diagnostic criteria, and 14.2% later developed sufficient features (total n = 80). Choroidal neurofibromas were present in 75.7% of patients that had NIR imaging and met diagnostic criteria, and detected in the absence of, or prior to Lisch nodules in 13.5%. Progression in the size and number of choroidal neurofibromas occurred in 26 eyes (32.5%) of 14 patients (35.0%), all under 16 years old. Patients without choroidal neurofibromas at first examination never developed them over the study period.
Conclusion: Choroidal neurofibromas, detected by NIR imaging, are common in NF1, present early with frequent progression, and represent an additional tool to aid NF1 diagnosis in young children.

Entities:  

Keywords:  Neurofibromatosis Type 1; choroidal imaging; choroidal neurofibromas; confocal scanning laser ophthalmoscopy; near-infrared reflectance

Mesh:

Substances:

Year:  2021        PMID: 33594930     DOI: 10.1080/13816810.2021.1881977

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  3 in total

1.  Neuroretinal dysfunction in patients affected by neurofibromatosis type 1.

Authors:  Antonietta Moramarco; Luca Lucchino; Fabiana Mallone; Michela Marcelli; Ludovico Alisi; Vincenzo Roberti; Sandra Giustini; Alessandro Lambiase; Marcella Nebbioso
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

2.  Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1.

Authors:  Mariana Flores Pimentel; Anna Heath; Michael J Wan; Rowaida Hussein; Kate E Leahy; Heather MacDonald; Erika Tavares; Cynthia VandenHoven; Katelyn MacNeill; Peter Kannu; Patricia C Parkin; Elise Heon; Arun Reginald; Ajoy Vincent
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

3.  Choroidal Abnormalities in Pediatric NF1: A Cohort Natural History Study.

Authors:  Eleonora Cosmo; Luisa Frizziero; Giacomo Miglionico; Chiara Sofia De Biasi; Marisa Bruno; Eva Trevisson; Ilaria Gabbiato; Giulia Midena; Raffaele Parrozzani
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.